Results 131 to 140 of about 5,489,565 (248)
Prevention of Early Onset of Breast Cancer With Ashwagandha
ABSTRACT Prevention of breast cancer is feasible because many risk factors for this malignancy are known (e.g., family history, reproductive factors, etc.). Medicinal plants and/or their bioactive phytochemicals are attractive for the prevention of early onset of breast cancer due to their generally favorable safety profile.
Eun‐Ryeong Hahm +2 more
wiley +1 more source
Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
Wilson, Robert F., Henry, Timothy D.
openaire +1 more source
Naturally occurring and therapy-induced antibodies to human granulocyte colony stimulating factor (G-CSF) in human ...
Laricchia Robbio L. +4 more
core
SHP2 in Cancer: From Tumor Biology to Therapeutic Targeting
ABSTRACT SHP2 is a tyrosine phosphatase that mediates intracellular signaling downstream of transmembrane receptors regulated by a pair of src homology 2 (SH2) domains. Its overexpression and mutation are pivotal in driving tumor progression by influencing various cancer's fundamental characteristics, such as metastasis, DNA repair, angiogenesis ...
Maryam Jama +2 more
wiley +1 more source
The Audiologic and Otolaryngologic Phenotype in WHIM Syndrome
Abstract Objective WHIM syndrome (warts, hypogammaglobulinemia, infections, and myelokathexis syndrome) is an ultra‐rare primary immunodeficiency disease caused by autosomal dominant hyperfunctional mutations in the chemokine receptor CXCR4. Otolaryngologists are frequently consulted to evaluate WHIM patients because of recurrent acute ear and sinus ...
Christopher K. Zalewski +7 more
wiley +1 more source
Background/Aims: We created a study group in order to investigate the effects of splenectomy and filgrastim. Filgrastin, is an immunomodulator granulocyte colony-stimulating factor (G-CSF), that affects bacterial ...
DOĞUSOY, GÜLEN +4 more
core +1 more source
Receptor for Granulocyte Colony-Stimulating Factor
NAGATA, S., FUKUNAGA, R.
openaire +3 more sources
ABSTRACT Sickle cell disease (SCD) affects millions worldwide but has limited treatment options, most of which carry significant side effects. At present, the only curative treatment for SCD is allogeneic or gene‐modified autologous hematopoietic stem cell (HSC) transplantation (Tx).
Oluwaseun O. Babatunde +4 more
wiley +1 more source
Evaluation of serum granulocyte colony stimulating factor levels in infants of preeclamptic mothers
In this study we aimed to evaluate the relationship between serum granulocyte colony stimulating factor (G-CSF) levels and absolute neutrophil counts (ANC) in infants of preeclamptic ...
Tekinalp, Gulsevin +6 more
core
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre +5 more
wiley +1 more source

